2013 annual financial data

Celldex Therapeutics, Inc. 2013 Operating margin

Celldex Therapeutics, Inc. 2013 operating margin with verified reported values.

Direct answer

Operating margin was -1,981.08%.

Operating income was -81,442,000 USD and net income was -81,550,000 USD.
Operating cash flow was -67,669,000 USD.

Get free Celldex Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,111,000 USD
Operating income
-81,442,000 USD
Net income
-81,550,000 USD
Operating cash flow
-67,669,000 USD